## Abstract ## Background: Deletions and duplications of single exons or exon groups account for a large proportion of the __PARK2__ gene mutations described in juvenile autosomal recessive Parkinson's disease (PD). ## Methods: We analyzed rearrangements in exons 1 to 12 of the __PARK2__ gene in
Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson's disease
β Scribed by Greg T. Sutherland; Gerhard A. Siebert; Jeremy R. B. Newman; Peter A. Silburn; Richard S. Boyle; John D. O'Sullivan; George D. Mellick
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 905 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Familial Parkinsonism (PARK) genes are strong candidates for conferring susceptibility to common forms of PD. However, most studies to date have provided little evidence that their common variants substantially influence disease risk. Recently, mutations were described in the gene, GIGYF2 (TNRC15), located at the __PARK__11 locus (2q37.1). Here, we use a haplotype tagging approach to examine common variation in the GIGYF2 gene and PD risk. PD cases (n = 568) and age and genderβmatched control subjects (n = 568) were recruited from three specialist movement disorder clinics in Brisbane (Australia) and the Australian electoral roll. Twelve tagging SNPs were assessed in all subjects and haplotype and genotype associations were explored. Overall our findings suggest that common genetic variants of GIGYF2 do not significantly affect sporadic PD risk in Australian Caucasians. Β© 2008 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract Ξ±βSynuclein is one of the main components of Lewy bodies, a pathological marker of Parkinson's disease (PD). Certain missense mutations of the Ξ±βsynuclein gene cause familial PD, but the role of the gene in sporadic PD is still controversial. We scrutinized polymorphisms of the Ξ±βsynucl
## Abstract Parkinson's disease (PD) is a common progressive neurodegenerative disorder characterized clinically by a combination of motor symptoms. Identifying novel PD genetic risk factors is important for understanding its pathogenesis. A recent study suggested that up to 21% of subjects with PD
## Abstract Among 242 patients with apparently sporadic Parkinson's disease, a 70βyearβold man with a CAG repeat number of 37 in the __SCA2__ gene was identified. He has remained responsive to levodopa 14 years after onset and has had no overt signs suggesting cerebellar dysfunction. Although it is